![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessOccupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study
Incidence rates of lymphoma are usually higher in men than in women, and oestrogens may protect against lymphoma.
-
Article
Open AccessComment on: ‘Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study’
-
Article
Open AccessAntibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case–control study
Kaposi's sarcoma-associated herpes virus is associated with primary effusion lymphoma and multicentric Castleman's disease.
-
Article
Open AccessHealth and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
Cervical cancer is a leading cause of cancer death among women in low-income countries, with ∼25% of cases worldwide occurring in India. We estimated the potential health and economic impact of different cervi...
-
Article
Open AccessHPV and cervical cancer: screening or vaccination?
Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer preventio...
-
Article
Open AccessTobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case–control study (EPILYMPH)
We analysed the effects of tobacco and alcohol in the aetiology of Hodgkin's lymphoma (HL), based on 340 cases and 2465 controls enrolled in Spain, France, Italy, Germany, Ireland and Czech Republic, between 1...
-
Article
Open AccessRisk of malignant lymphoma associated with human herpesvirus-8: a case–control study in Spain
No overall increased risk of lymphoma associated with antibodies to human herpesvirus-8 was found in 526 lymphomas and 599 controls (odds ratio (OR)=1.04, 95% confidence interval (CI)=0.62–1.75); significant i...